We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PQ
3226
DELISTED
Petroquest Energy Inc Wd
PQ
$24K ﹤0.01%
12,050
+125
+1% +$288
SDR
3227
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$24K ﹤0.01%
16,771
+4,080
+32% +$5.94K
AZN icon
3228
CALL
AstraZeneca
AZN
$252B
$23K ﹤0.01%
9,200
CRM icon
3229
CALL
Salesforce
CRM
$158B
$23K ﹤0.01%
15,600
+3,400
+28% +$296K
ECT
3230
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$23K ﹤0.01%
10,850
JONE
3231
DELISTED
Jones Energy, Inc.
JONE
$23K ﹤0.01%
708
+57
+9% +$2.3K
CANF
3232
Can-Fite BioPharma American Depositary Shares
CANF
$6.86M
$22K ﹤0.01%
+4
New +$22K
KHC icon
3233
CALL
Kraft Heinz
KHC
$30.2B
$22K ﹤0.01%
134,800
+64,600
+92% +$5.86M
MAT icon
3234
CALL
Mattel
MAT
$4.25B
$22K ﹤0.01%
+44,900
New +$1.01M
PLUG icon
3235
Plug Power
PLUG
$2.97B
$22K ﹤0.01%
10,834
+500
+5% +$1.05K
PLUR icon
3236
Pluri
PLUR
$19.4M
$22K ﹤0.01%
212
+66
+45% +$7.3K
RT
3237
DELISTED
Ruby Tuesday Georgia
RT
$22K ﹤0.01%
+11,000
New +$26.1K
IWM icon
3238
CALL
iShares Russell 2000 ETF
IWM
$83.4B
$21K ﹤0.01%
25,500
+7,500
+42% +$1.04M
MCD icon
3239
CALL
McDonald's
MCD
$194B
$21K ﹤0.01%
+11,500
New +$1.66M
NAK
3240
Northern Dynasty Minerals
NAK
$953M
$21K ﹤0.01%
15,114
-5,000
-25% -$8.01K
SBUX icon
3241
CALL
Starbucks
SBUX
$120B
$19K ﹤0.01%
89,300
-2,300
-3% -$139K
ATHX
3242
DELISTED
Athersys, Inc. Common Stock
ATHX
$19K ﹤0.01%
+497
New +$18.5K
SYF icon
3243
CALL
Synchrony
SYF
$25.9B
$18K ﹤0.01%
45,500
-200
-0.4% -$5.93K
IDXG
3244
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$18K ﹤0.01%
2,000
+720
+56% +$14.1K
VIAB
3245
CALL
DELISTED
Viacom Inc. Class B
VIAB
$18K ﹤0.01%
61,600
+5,500
+10% +$209K
WLL
3246
CALL
DELISTED
Whiting Petroleum Corporation
WLL
$18K ﹤0.01%
329
+118
+56% +$270K
CVS icon
3247
CALL
CVS Health
CVS
$126B
$17K ﹤0.01%
17,700
+6,100
+53% +$482K
GAU
3248
Galiano Gold
GAU
$502M
$17K ﹤0.01%
10,940
UMPQ
3249
CALL
DELISTED
Umpqua Holdings Corp
UMPQ
$17K ﹤0.01%
31,100
-1,700
-5% -$30.1K
SDRL
3250
CALL
DELISTED
Seadrill Limited Common Stock
SDRL
$17K ﹤0.01%
1,279
-48
-4% -$7.54K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.